NEU 3.50% $14.05 neuren pharmaceuticals limited

From a Shareholders' perspective NEU has performed remarkably...

  1. 2,762 Posts.
    lightbulb Created with Sketch. 389
    From a Shareholders' perspective NEU has performed remarkably poorly relative to the drug pipeline's ODD emphasis, advanced Phases, and cash on hand.

    From a Sufferers', Parents', and Carers' perspective NEU is one of very few biotechs that have provided real hope, and I'm sure is the subject of a few prayers.

    From My perspective I'm financially able to wait, and even to selectively nibble away small amounts.

    Family for now... and forever!

    OV

    ABCDEFGHIJKMNOPQRSTUVWXYZ! (Nod to Hitchcock's Christmas Greeting.)
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.05
Change
-0.510(3.50%)
Mkt cap ! $1.795B
Open High Low Value Volume
$14.38 $14.42 $13.94 $6.419M 454.6K

Buyers (Bids)

No. Vol. Price($)
1 500 $13.99
 

Sellers (Offers)

Price($) Vol. No.
$14.07 6644 4
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.